Toyota Motor Corporation (TMCO34)
B3 Stock Exchange · Brazil · prices in BRL · close of 27 Oct 2026
Key indicators
| Last close | BRL 65.88 |
|---|---|
| 52-week range | 53.85 – 81.28 |
| Return, 1 month / 3 months | +9.1% / +13.2% |
| Return, 1 year / 3 years | −5.1% / +28.8% |
| Trend | Uptrend |
| RSI (14) | 66 |
| Volatility (1 year) | 28.6% |
| Worst drawdown (1 year) | -32.6% |
| Average daily value traded | 0.11M BRL |
| Dividend yield | 0.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Toyota Motor Corporation is a Japanese vehicle manufacturer based in Toyota City. It designs and builds passenger cars, sport utility vehicles, trucks and buses, selling them under the Toyota and Lexus brands along with its Hino commercial vehicle arm. Its model range includes the Corolla, Camry, Prius and Land Cruiser. Customers are individual drivers, businesses and fleet operators in markets around the world, and the company also provides financing and related services for vehicle owners and dealers.
Toyota Motor Corporation is represented on the B3 Stock Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code TMCO34, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Toyota Motor Corporation (TMCO34) trades on the B3 Stock Exchange in Brazil. It last closed at BRL 65.88 on 27 October 2026.
Its price-based Market X-Ray is 49 out of 100 (a weak price profile), ranking 772 of 1,455 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 5.1% and over the last three months it rose 13.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on B3 Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 42 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | 3.2% | ||
| From 52-week high | -18.6% | ||
| Momentum | 52 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 13.2% | ||
| 6-month return | 9.6% | ||
| 12-month return, skipping the last month | -13.0% | ||
| Stability (higher is calmer) | 60 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 28.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -32.6% | ||
| Liquidity | 59 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.11M BRL | ||
| Zero-volume days | 0.0% | ||
| Income | 18 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.0% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Income: Dividend is small or irregular.
Returns
| 1 week | +6.7% |
|---|---|
| 1 month | +9.1% |
| 3 months | +13.2% |
| 6 months | +9.6% |
| 1 year | −5.1% |
| 3 years | +28.8% |
| 5 years | +67.6% |
Signals
| 50-day / 200-day average | 61.50 / 63.82 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.84 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 27 Mar 2026 | JPY 0.8189 |
| 26 Sep 2025 | JPY 0.7903 |
| 27 Mar 2025 | JPY 0.9789 |
| 26 Sep 2024 | JPY 0.7965 |
| 26 Mar 2024 | JPY 0.7628 |
| 27 Sep 2023 | JPY 0.4960 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on B3 Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.